New hope for atrial fibrillation: proteins as the key to early diagnosis!

New hope for atrial fibrillation: proteins as the key to early diagnosis!

atrial fibrillation is an insidious heart rhythm disorder that affects around every third person in the course of his life, as numerous experts warn. This disease leads to chaotic heartbeats and can result in serious consequences such as strokes or heart failure. The fact that it often runs asymptomatic and therefore remains undetected. A newly launched research project at the University Hospital in Würzburg (VHF) aims to better understand the mechanisms behind atrial fibrillation. Under the direction of experts like Prof. Dr. Thomas Fischer are examined proteins that could possibly act as a biomarker for the disease in order to develop preventive measures. This was made possible by promoting the Adolf and Edith Schießer Foundation, which contributed 10,000 euros to research.

risk of stroke and treatment options

In the context of the treatment of atrial fibrillation, it is crucial to determine the risk of stroke of those affected. The Cha2DS2-VASC score is used for this, which takes into account various risk factors such as high blood pressure, diabetes and previous thromboembolia. The more risk factors are taken into account, the more urgent it is to take blood thinners, either traditional coumarine or recent direct oral anticoagulants (doaks). These preventive measures are essential to avoid serious complications, as it is emphasized in a report by the German Heart Foundation. The latest studies also show that catheter ablation that serves to restore a normal heart rhythm is one of the most effective treatments, especially if other therapies do not bring the desired success.

The use of innovative therapies and diagnoses is crucial in the fight against atrial fibrillation, current research interest is the analysis of proteins in patients with heart failure. In the future, these findings could help recognize atrial fibrillation at an early stage and to treat them more effectively. Aukk reported on the initiative for exploring the underlying biomolecular mechanisms, while the German Heart Foundation underlined the importance of individual stroke prevention and the timely treatment of atrial fibrillation. These developments show how important early intervention and precise diagnosis in modern cardiology are.